NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 46 of 46 results found.

Activity Company Description Location
Company Altis BioSystems Inc. Activity: Research and Development Research and Development Company Description Altis Biosystems has developed a patented stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. Location Durham
Company Artizan Biosciences Inc. Activity: Research and Development Research and Development Company Description Artizan is developing a platform for identifying and targeting pathogenic intestinal bacteria, with a focus on inflammatory bowel disease and potential applications in autoimmune diseases, obesity, skin, lung and central nervous system diseases. Location Durham
Company Astral Genetics Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Astral Genetics offers a range of fee-for-service products relating to the generation and characterization of mouse and human induced pluripotent Stem Cells (iPS). Location Winston-Salem
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company Biofidelity Inc. Activity: Research and Development Research and Development Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. Location Morrisville
Company Biorg Inc. Activity: Research and Development Research and Development Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. Location Winston-Salem
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company Celldom Inc. Activity: Research and Development Research and Development Company Description Celldom is developing next generation, high throughput single cell analysis technology with applications in research, drug discovery and drug development. Its technology enables the investigation of diversity in large cell populations. Location Durham
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Research Triangle Park
Company Cereius Inc. Activity: Research and Development Research and Development Company Description Cereius is developing novel radio-labeled therapeutics for treating solid tumor brain metastasis. Location Durham
Company CLAIRIgene LLC Activity: Research and Development Research and Development Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company CytexOrtho Activity: Research and Development Research and Development Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. Location Durham
Company Data Driven Bioscience Inc. Activity: Research and Development Research and Development Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. Location Durham
Company Denizen Biologics LLC Activity: Research and Development Research and Development Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. Location Cary
Company Dualogics LLC Activity: Research and Development Research and Development Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. Location Durham
Company Eldec Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Eldec Pharmaceuticals is developing anti-inflammatory peptides for the treatment of chronic lung disease. Location Durham
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Morrisville
Company Enzyvant Inc. Activity: Research and Development Research and Development Company Description Enzyvant, a subsidiary of Sumitovant Biopharma, develops regenerative therapeutics for rare diseases such as congenital athymia. Location Durham
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation. Location Morrisville
Company FastBack Bio LLC Activity: Research and Development Research and Development Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. Location Raleigh
Company FLAG Therapeutics Inc. Activity: Research and Development Research and Development Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. Location Raleigh
Company GeneCentric Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. Location Research Triangle Park
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. Location Raleigh
Company GENIE Therapeutics Activity: Research and Development Research and Development Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. Location Winston-Salem
Company GSK (RTP) Activity: Research and Development Research and Development Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. Location Durham
Company Gusto Global LLC Activity: Research and Development Research and Development Company Description Gusto Global is developing a discovery and discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. Location Research Triangle Park
Company Inceptor Bio LLC Activity: Research and Development Research and Development Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. Location Raleigh
Company Juno Metabolomics LLC Activity: Production and Manufacturing Production and Manufacturing Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. Location Chapel Hill
Company Lucerno Dynamics LLC Activity: Research and Development Research and Development Company Description Lucerno Dynamics is commercializing a medical device for quality control, dosimetry, and quality assurance for nuclear medicine. Future applications of the technology include rheumatoid arthritis, immunotherapy, and chemotherapy assessment. Location Cary
Company Meryx Inc. Activity: Research and Development Research and Development Company Description Meryx is developing small-molecule, orally-bioavailable RTK inhibitors that inhibit growth and initiate anti-tumor immunity in hematologic and solid malignancies. Location Chapel Hill
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Chapel Hill
Company Panaceutics Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Panaceutics provides customized nutritional solutions for businesses and individuals. Location Research Triangle Park
Company Path BioAnalytics Inc. Activity: Research and Development Research and Development Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. Location Durham
Company Pfizer (Morrisville) Activity: Research and Development Research and Development Company Description Pfizer (Morrisville) progresses gene therapy clinical candidates, develops robust, scalable and compliant processes and conducts analytical testing for drug substance manufacture. Location Morrisville
Company Pfizer Inc. (Durham) Activity: Research and Development Research and Development Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. Location Durham
Company Pfizer Inc. (Sanford) Activity: Production and Manufacturing Production and Manufacturing Company Description Pfizer's Sanford facility manufactures clinical trial and commercial materials for conjugate vaccines and gene therapies. Location Sanford
Company PhosphoGam Inc. Activity: Research and Development Research and Development Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. Location Durham
Company Precise Bio Inc. Activity: Research and Development Research and Development Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. Location Winston-Salem
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Sapere Bio Inc. Activity: Research and Development Research and Development Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. Location Research Triangle Park
Company Sarepta Therapeutics Inc. (Durham) Activity: Research and Development Research and Development Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. Location Durham
Company Tellus Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Location Hillsborough
Company Ten63 Therapeutics Inc. Activity: Research and Development Research and Development Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. Location Durham
Company TregTherapeutics Inc. Activity: Research and Development Research and Development Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The company is currently developing a tolerogenic vaccine to eradicate multiple sclerosis. Location Chapel Hill
Company Zinfandel Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. Location Chapel Hill